[Bronchospasmolysis in chronic obstructive respiratory tract disease. Clinico-pathological studies using theophylline-ethylenediamine, diprophylline, and hexoprenaline].
D000402:Airway Obstruction / Q000188:drug therapy*; D000628:Aminophylline / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy*; D002908:Chronic Disease; D005029:Ethylenediamines / Q000627:therapeutic use; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use; D006594:Hexoprenaline / Q000627:therapeutic use*; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use*; D013806:Theophylline / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D005029:Ethylenediamines; D010627:Phenethylamines; D005280:Fenoterol; D000628:Aminophylline; D013806:Theophylline; D006594:Hexoprenaline; D009241:Ipratropium
Bronchospasmolyse bei chronisch obstruktiver Atemwegserkrankung. Klinisch-pharmakologische Untersuchungen mit Theophyllin-Athylendiamin, Diprophyllin und Hexoprenalin.